Dexamethasone: A Potent Synthetic Glucocorticoid
Dexamethasone is a potent, long-acting synthetic glucocorticoid with significant anti-inflammatory, immunosuppressive, and anti-allergic properties that is approximately 25 times more potent than short-acting corticosteroids like hydrocortisone. 1
Pharmacological Properties
- Potency: 25 times more potent than hydrocortisone with a half-life of 36-72 hours 2
- Duration: Long-acting with a half-life of 36-72 hours 2
- Equivalent doses: 0.1 mg dexamethasone equals 10 mg hydrocortisone; 8 mg dexamethasone equals 200 mg hydrocortisone 2
- Formulations: Available as oral tablets, injectable solutions (IV/IM), and other preparations 3, 4
- Mineralocorticoid activity: Lacks significant mineralocorticoid activity, making it unsuitable as sole therapy for primary adrenal insufficiency 2
Clinical Applications
Oncology
- Chemotherapy-induced nausea/vomiting: Standard antiemetic prophylaxis in moderate to high emetic risk chemotherapy 5
- High emetic risk: Dexamethasone 20 mg day 1, then 8 mg days 2-4
- Moderate emetic risk: Dexamethasone 8 mg on day 1 (single dose)
- Low emetic risk: Dexamethasone 8 mg (single dose) 5
Hematologic Malignancies
- Acute Lymphoblastic Leukemia (ALL): Core component of induction therapy alongside vincristine, anthracyclines, and asparaginase 5
Immunotherapy Complications
- Cytokine Release Syndrome (CRS):
- Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS):
- Grade 2: Dexamethasone 10 mg IV, may repeat every 6-12 hours if no improvement
- Grade 3: Dexamethasone 10 mg IV every 6 hours
- Grade 4: High-dose methylprednisolone 1000 mg/day 5
Infectious Diseases
- Bacterial Meningitis: Adjunctive therapy to reduce neurological sequelae and hearing loss 5
Perioperative Use
- PONV Prevention: Single dose of 4-5 mg has similar efficacy to 8-10 mg 5
- The DREAMS trial confirmed that a single 8 mg dose reduced PONV for up to 72 hours 5
Side Effects and Risks
Short-term use: Generally well-tolerated with minimal adverse effects 2
- Hyperglycemia
- Sleep disturbances
- Epigastric burning sensation
Long-term use: Significant adverse effects 6
Special Considerations
- In ALL treatment, dexamethasone is associated with higher risk of osteonecrosis, infection, and induction mortality compared to prednisone, despite better CNS penetration 5
- For short-term use (<1 week), dexamethasone can be discontinued rapidly without tapering 2
- For longer use (>3 weeks), gradual tapering is recommended to prevent adrenal insufficiency 2
- When used for bacterial meningitis, dexamethasone should be discontinued if the causative organism is determined not to be H. influenzae or S. pneumoniae 5
Dosing Recommendations
- Single daily dosing is possible due to long half-life and excellent bioavailability 2
- Tapering schedule for prolonged use (from 16 mg): 12 mg/day for 2-3 days → 8 mg/day for 2-3 days → 4 mg/day for 2-3 days → 2 mg/day for 2-3 days before discontinuation 2
- Dose adjustments may be needed for patients taking CYP3A4 inducers or those who are obese 2
Dexamethasone's potency, long half-life, and minimal mineralocorticoid effects make it a valuable therapeutic option across multiple medical specialties, but its use must be balanced against potential adverse effects, particularly with prolonged administration.